Single answer
Is ACADIA Pharmaceuticals Inc (ACAD) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
What is the conclusion?
Right now our advanced algorithms say:
$1 invested is now $1.48 or 47.59%
(In 50 weeks 12 hours 13 minutes and 18 seconds .)
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for ACADIA Pharmaceuticals Inc is $34.00, which is $7.30 (27.34%) above the current price today's price.
Low target: $29.00 | High target: $37.00
Company snapshot
A quick overview of the business and its public profile.
ACADIA Pharmaceuticals Inc a biopharmaceutical company focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders The company offers NUPLAZID pimavanserin for the treatment of hallucinations and delusions associated with Parkinsons disease psychosis Its pipeline include pimavanserin under phase 3 development for the treatment of Alzheimers disease psychosis and negative symptoms of schizophrenia Trofinetide a novel synthetic analog under phase 3 development for the treatment of Rett syndrome ACP044 a novel firstinclass orally administered nonopioid analgesic under phase 2 development for treating acute and chronic pain and ACP319 a positive allosteric modulator of the muscarinic receptor under phase 1 development for treating schizophrenia and cognition in Alzheimers ACADIA Pharmaceuticals Inc was founded in 1993 and is headquartered in San Diego California
Website: https://www.acadia-pharm.com
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.05. Cash flow to debt ratio: 3.34. Net profit margin: 21.80%. Inflation risk score: low (0.00/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for ACADIA Pharmaceuticals Inc is $44.8M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
On ACADIA Pharmaceuticals Inc, 2015-12-31 had a stock price of $35.65. If you invested back then, your return now would be a loss of $8.95 per share or 25.11%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.